Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC)
Publication
, Conference
Thakar, MS; Logan, B; Buckley, RH; Haddad, E; Dvorak, CC; O'Reilly, RJ; Kapoor, N; Satter, LF; Martinez, C; Pai, S-Y; Heimall, J; Jyonouchi, S ...
Published in: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
March 1, 2020
Duke Scholars
Published In
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
EISSN
1523-6536
ISSN
1083-8791
Publication Date
March 1, 2020
Volume
26
Issue
3
Start / End Page
S18 / S19
Location
Orlando, FL
Publisher
ELSEVIER SCIENCE INC
Conference Name
Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Thakar, M. S., Logan, B., Buckley, R. H., Haddad, E., Dvorak, C. C., O’Reilly, R. J., … Notarangelo, L. D. (2020). Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC). In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (Vol. 26, pp. S18–S19). Orlando, FL: ELSEVIER SCIENCE INC.
Thakar, Monica S., Brent Logan, Rebecca H. Buckley, Elie Haddad, Christopher C. Dvorak, Richard J. O’Reilly, Neena Kapoor, et al. “Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC).” In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26:S18–19. ELSEVIER SCIENCE INC, 2020.
Thakar MS, Logan B, Buckley RH, Haddad E, Dvorak CC, O’Reilly RJ, et al. Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC). In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC; 2020. p. S18–9.
Thakar, Monica S., et al. “Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC).” BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 26, no. 3, ELSEVIER SCIENCE INC, 2020, pp. S18–19.
Thakar MS, Logan B, Buckley RH, Haddad E, Dvorak CC, O’Reilly RJ, Kapoor N, Satter LF, Martinez C, Pai S-Y, Heimall J, Jyonouchi S, Sullivan KE, Chandra S, Smith AR, Chaudhury S, Saldana BD, Sunkersett G, Shyr DC, Burroughs LM, Petrovic A, Quigg TC, Shenoy S, Bednarski JJ, DeSantes K, Cuvelier GDE, Chandrakasan S, Gillio AP, Knutsen AP, Eissa H, Goldman F, Moore TB, Aquino V, Shereck E, Lugt MV, Caywood EH, Yu LC, Rozmus J, Talano J-AM, Malech HL, Shah AJ, Abu-Arja R, Miller HK, Bani-Hashemi T, Chang CK, Dunn E, Torgerson T, Pulsipher MA, Griffith LM, Cowan MJ, Kohn DB, Puck J, Notarangelo LD. Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC; 2020. p. S18–S19.
Published In
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
EISSN
1523-6536
ISSN
1083-8791
Publication Date
March 1, 2020
Volume
26
Issue
3
Start / End Page
S18 / S19
Location
Orlando, FL
Publisher
ELSEVIER SCIENCE INC
Conference Name
Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences